Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-11-11 Purchase |
2022-11-14 4:13 pm |
GLYCOMIMETICS INC | GLYC | Hahn Brian M. SVP Finance, CFO |
20,000 | $1.06 | $21,200 | 56,843 (Direct) |
View |
| 2022-11-11 Purchase |
2022-11-14 4:11 pm |
GLYCOMIMETICS INC | GLYC | Magnani John L. SVP of Research, CSO |
45,045 | $1.17 | $52,703 | 370,923 (Indirect Direct) |
View |
| 2022-11-11 Purchase |
2022-11-14 4:04 pm |
GLYCOMIMETICS INC | GLYC | Girard Armand SVP, Chief Business Officer |
6,500 | $1.05 | $6,825 | 29,161 (Direct) |
View |
| 2022-03-09 Sale |
2022-03-10 5:06 pm |
GLYCOMIMETICS INC | GLYC | Magnani John L. SVP of Research, CSO |
3,227 | $1.09 | $3,517 | 325,878 (Indirect Direct) |
View |
| 2022-03-09 Sale |
2022-03-10 5:05 pm |
GLYCOMIMETICS INC | GLYC | Girard Armand SVP, Chief Business Officer |
2,339 | $1.09 | $2,550 | 22,661 (Direct) |
View |
| 2022-03-09 Sale |
2022-03-10 5:03 pm |
GLYCOMIMETICS INC | GLYC | Hahn Brian M. SVP Finance, CFO |
2,917 | $1.09 | $3,180 | 36,843 (Direct) |
View |
| 2021-11-16 Purchase |
2021-11-18 4:05 pm |
GLYCOMIMETICS INC | GLYC | Andrews Patricia S Director |
40,000 | $2.05 | $82,000 | 45,250 (Direct) |
View |
| 2020-12-28 Sale |
2020-12-30 4:00 pm |
GLYCOMIMETICS INC | GLYC | King Rachel K. President, CEO |
84,176 | $3.91 | $329,128 | 531,206 (Indirect Direct) |
View |
| 2020-11-04 Purchase |
2020-11-06 6:33 pm |
GLYCOMIMETICS INC | GLYC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
1,266,737 | $2.6 | $3,293,516 | 630,453 (Direct) |
View |
| 2020-10-30 Purchase |
2020-11-03 4:44 pm |
GLYCOMIMETICS INC | GLYC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
932,612 | $2.75 | $2,564,683 | 544,363 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-09-02 Option Award |
2022-09-07 4:10 pm |
N/A 2032-09-01 |
GLYCOMIMETICS INC | GLYC | Rock Edwin Chief Medical Officer |
200,000 | $0 | 200,000 (Direct) |
View |
Ownership |
2022-09-07 4:08 pm |
N/A N/A |
GLYCOMIMETICS INC | GLYC | Rock Edwin Chief Medical Officer |
0 | $0 | 0 (Direct) |
View |
| 2022-05-18 Option Award |
2022-05-20 4:20 pm |
N/A 2032-05-17 |
GLYCOMIMETICS INC | GLYC | PEARSON TIMOTHY R Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2022-05-18 Option Award |
2022-05-20 4:19 pm |
N/A 2032-05-17 |
GLYCOMIMETICS INC | GLYC | Koenig Scott Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2022-05-18 Option Award |
2022-05-20 4:16 pm |
N/A 2032-05-17 |
GLYCOMIMETICS INC | GLYC | King Rachel K. Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2022-05-18 Option Award |
2022-05-20 4:13 pm |
N/A 2032-05-17 |
GLYCOMIMETICS INC | GLYC | JUNIUS DANIEL M Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2022-05-18 Option Award |
2022-05-20 4:10 pm |
N/A 2032-05-17 |
GLYCOMIMETICS INC | GLYC | Jackson Scott Thomas Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2022-05-18 Option Award |
2022-05-20 4:08 pm |
N/A 2032-05-17 |
GLYCOMIMETICS INC | GLYC | Goldberg Mark Alan Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2022-05-18 Option Award |
2022-05-20 4:06 pm |
N/A 2032-05-17 |
GLYCOMIMETICS INC | GLYC | Andrews Patricia S Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2022-01-21 Option Award |
2022-01-25 9:02 pm |
N/A 2032-01-20 |
GLYCOMIMETICS INC | GLYC | Girard Armand SVP, Chief Business Officer |
192,400 | $0 | 192,400 (Direct) |
View |
| 2022-01-21 Option Award |
2022-01-25 9:01 pm |
N/A 2032-01-20 |
GLYCOMIMETICS INC | GLYC | Magnani John L. SVP of Research, CSO |
125,000 | $0 | 125,000 (Direct) |
View |
| 2022-01-21 Option Award |
2022-01-25 8:59 pm |
N/A 2032-01-20 |
GLYCOMIMETICS INC | GLYC | Hahn Brian M. SVP Finance, CFO |
212,400 | $0 | 212,400 (Direct) |
View |
| 2022-01-21 Option Award |
2022-01-25 8:58 pm |
N/A 2032-01-20 |
GLYCOMIMETICS INC | GLYC | Semerjian Harout Chief Executive Officer |
423,500 | $0 | 423,500 (Direct) |
View |
Ownership |
2021-08-10 4:16 pm |
N/A N/A |
GLYCOMIMETICS INC | GLYC | Semerjian Harout Chief Executive Officer |
0 | $0 | 1,647,600 (Direct) |
View |
| 2021-05-18 Option Award |
2021-05-27 8:58 pm |
N/A 2031-05-17 |
GLYCOMIMETICS INC | GLYC | JUNIUS DANIEL M Director |
15,750 | $0 | 53,750 (Direct) |
View |
| 2021-05-18 Option Award |
2021-05-27 8:55 pm |
N/A 2031-05-17 |
GLYCOMIMETICS INC | GLYC | Jackson Scott Thomas Director |
15,750 | $0 | 15,750 (Direct) |
View |
| 2021-05-18 Option Award |
2021-05-27 8:54 pm |
N/A 2031-05-17 |
GLYCOMIMETICS INC | GLYC | Andrews Patricia S Director |
15,750 | $0 | 15,750 (Direct) |
View |
| 2021-05-18 Option Award |
2021-05-27 8:51 pm |
N/A 2031-05-17 |
GLYCOMIMETICS INC | GLYC | Goldberg Mark Alan Director |
15,750 | $0 | 27,247 (Direct) |
View |
| 2021-05-18 Option Award |
2021-05-27 8:49 pm |
N/A 2031-05-17 |
GLYCOMIMETICS INC | GLYC | Koenig Scott Director |
15,750 | $0 | 15,750 (Direct) |
View |
| 2021-05-18 Option Award |
2021-05-27 8:47 pm |
N/A 2031-05-17 |
GLYCOMIMETICS INC | GLYC | PEARSON TIMOTHY R Director |
15,750 | $0 | 15,750 (Direct) |
View |
Ownership |
2021-03-08 4:14 pm |
N/A N/A |
GLYCOMIMETICS INC | GLYC | Feldman Eric Jay Chief Medical Officer |
0 | $0 | 210,498 (Direct) |
View |
| 2021-01-20 Option Award |
2021-01-22 4:07 pm |
N/A 2031-01-19 |
GLYCOMIMETICS INC | GLYC | Girard Armand SVP, Chief Business Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2021-01-20 Option Award |
2021-01-22 4:06 pm |
N/A 2031-01-19 |
GLYCOMIMETICS INC | GLYC | Hahn Brian M. SVP Finance, CFO |
103,500 | $0 | 108,760 (Direct) |
View |
| 2021-01-20 Option Award |
2021-01-22 4:05 pm |
N/A 2031-01-19 |
GLYCOMIMETICS INC | GLYC | Thackray Helen M. SVP Clinical Development, CMO |
103,500 | $0 | 252,115 (Direct) |
View |
| 2021-01-20 Option Award |
2021-01-22 4:03 pm |
N/A 2031-01-19 |
GLYCOMIMETICS INC | GLYC | Magnani John L. SVP of Research, CSO |
103,500 | $0 | 398,105 (Direct) |
View |
| 2021-01-20 Option Award |
2021-01-22 4:00 pm |
N/A 2031-01-19 |
GLYCOMIMETICS INC | GLYC | King Rachel K. President, CEO |
288,750 | $0 | 819,956 (Direct) |
View |
| 2020-12-28 Exercise |
2020-12-30 4:00 pm |
N/A N/A |
GLYCOMIMETICS INC | GLYC | King Rachel K. President, CEO |
130,821 | $1.12 | 531,206 (Direct) |
View |
| 2020-12-28 Exercise |
2020-12-30 4:00 pm |
N/A 2021-01-04 |
GLYCOMIMETICS INC | GLYC | King Rachel K. President, CEO |
130,821 | $0 | 531,206 (Direct) |
View |
| 2020-12-16 Exercise |
2020-12-17 4:00 pm |
N/A N/A |
GLYCOMIMETICS INC | GLYC | Hahn Brian M. SVP Finance, CFO |
5,260 | $1.12 | 5,260 (Direct) |
View |
| 2020-12-16 Exercise |
2020-12-17 4:00 pm |
N/A 2021-01-04 |
GLYCOMIMETICS INC | GLYC | Hahn Brian M. SVP Finance, CFO |
5,260 | $0 | 5,260 (Direct) |
View |